Breast Neoplasms [clinicaltrials_resource:fd46a662c92164802f60e654a768351f]
Women's Health Initiative (WHI) [clinicaltrials:NCT00000611]A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer [clinicaltrials:NCT00001193]Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer [clinicaltrials:NCT00001239]Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer [clinicaltrials:NCT00001269]Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma [clinicaltrials:NCT00001270]A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer [clinicaltrials:NCT00001338]A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer [clinicaltrials:NCT00001378]A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patients [clinicaltrials:NCT00001384]Positron Emission Tomography in Patients With Breast Cancer [clinicaltrials:NCT00001385]Outcomes of Education and Counseling for BRCA1 Testing [clinicaltrials:NCT00001468]Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast Cancer [clinicaltrials:NCT00001493]A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer [clinicaltrials:NCT00001498]A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab [clinicaltrials:NCT00001805]Prospective Study of Health in Runners and Walkers [clinicaltrials:NCT00005494]clinicaltrials:NCT00021255Vaccination Against High Risk Breast Cancer Using Tumor Derived Heat Shock Protein 70 [clinicaltrials:NCT00027131]Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer. [clinicaltrials:NCT00034125]A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer. [clinicaltrials:NCT00034489]A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer [clinicaltrials:NCT00034827]This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Metastatic Breast Cancer [clinicaltrials:NCT00034918]EPO906 Therapy in Patients With Advanced Breast Cancer [clinicaltrials:NCT00035126]Phase 2 Study of TLK286 in Metastatic Breast Cancer [clinicaltrials:NCT00035841]Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies [clinicaltrials:NCT00036023]clinicaltrials:NCT00036270clinicaltrials:NCT00037609clinicaltrials:NCT00038103clinicaltrials:NCT00038467Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel [clinicaltrials:NCT00039780]Massage Therapy for Cancer-Related Fatigue [clinicaltrials:NCT00039793]Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal Women [clinicaltrials:NCT00040014]Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer [clinicaltrials:NCT00041652]Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver [clinicaltrials:NCT00041808]PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909) [clinicaltrials:NCT00043368]Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk [clinicaltrials:NCT00043472]Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer [clinicaltrials:NCT00044291]Evaluation of BAY59-8862 in Taxane-Resistant Metastatic Breast Cancer Patients [clinicaltrials:NCT00044525]Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients [clinicaltrials:NCT00046371]ABI-007 in Taxol Resistant Patients With Metastatic Breast Cancer [clinicaltrials:NCT00046514]Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer [clinicaltrials:NCT00046527]Phase II Study to Evaluate Tariquidar (XR9576), a Selective MDR-1 Inhibitor, in Chemotherapy Resistant Advanced Breast Cancer [clinicaltrials:NCT00048633]
condition [clinicaltrials_vocabulary:condition]
Women's Health Initiative (WHI) [clinicaltrials:NCT00000611]A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer [clinicaltrials:NCT00001193]Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer [clinicaltrials:NCT00001239]Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial [clinicaltrials:NCT00001250]Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer [clinicaltrials:NCT00001269]Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma [clinicaltrials:NCT00001270]A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer [clinicaltrials:NCT00001338]A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer [clinicaltrials:NCT00001378]A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patients [clinicaltrials:NCT00001384]Positron Emission Tomography in Patients With Breast Cancer [clinicaltrials:NCT00001385]Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy [clinicaltrials:NCT00001440]Outcomes of Education and Counseling for BRCA1 Testing [clinicaltrials:NCT00001468]Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast Cancer [clinicaltrials:NCT00001493]Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer [clinicaltrials:NCT00001496]A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer [clinicaltrials:NCT00001498]A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients [clinicaltrials:NCT00001504]Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer [clinicaltrials:NCT00001507]A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab [clinicaltrials:NCT00001805]Methods in Education for Breast Cancer Genetics [clinicaltrials:NCT00001806]Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients [clinicaltrials:NCT00001837]Microarray Analysis for Human Genetic Disease [clinicaltrials:NCT00001898]Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma [clinicaltrials:NCT00002455]Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer [clinicaltrials:NCT00002460]High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma [clinicaltrials:NCT00002465]Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer [clinicaltrials:NCT00002498]High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer [clinicaltrials:NCT00002509]clinicaltrials:NCT00002528clinicaltrials:NCT00002529Tamoxifen in Treating Women With High-Risk Breast Cancer [clinicaltrials:NCT00002542]Mitoxantrone With or Without Docetaxel in Treating Women With Metastatic Breast Cancer [clinicaltrials:NCT00002544]Nutrition Intervention in Treating Women With Breast Cancer [clinicaltrials:NCT00002564]Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer [clinicaltrials:NCT00002579]Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer [clinicaltrials:NCT00002580]Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer [clinicaltrials:NCT00002581]Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer [clinicaltrials:NCT00002582]Pyrazoloacridine in Treating Women With Metastatic Breast Cancer [clinicaltrials:NCT00002585]Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer [clinicaltrials:NCT00002616]Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer [clinicaltrials:NCT00002627]Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast Cancer [clinicaltrials:NCT00002628]Tamoxifen for the Prevention of Breast Cancer in High-Risk Women [clinicaltrials:NCT00002644]
condition browse [clinicaltrials_vocabulary:condition-browse]
Women's Health Initiative (WHI) [clinicaltrials:NCT00000611]A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer [clinicaltrials:NCT00001193]Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer [clinicaltrials:NCT00001239]Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial [clinicaltrials:NCT00001250]Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer [clinicaltrials:NCT00001269]Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma [clinicaltrials:NCT00001270]A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer [clinicaltrials:NCT00001338]A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer [clinicaltrials:NCT00001378]A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patients [clinicaltrials:NCT00001384]Positron Emission Tomography in Patients With Breast Cancer [clinicaltrials:NCT00001385]Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy [clinicaltrials:NCT00001440]Outcomes of Education and Counseling for BRCA1 Testing [clinicaltrials:NCT00001468]Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast Cancer [clinicaltrials:NCT00001493]Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer [clinicaltrials:NCT00001496]A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer [clinicaltrials:NCT00001498]A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients [clinicaltrials:NCT00001504]Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer [clinicaltrials:NCT00001507]A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab [clinicaltrials:NCT00001805]Methods in Education for Breast Cancer Genetics [clinicaltrials:NCT00001806]Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients [clinicaltrials:NCT00001837]Microarray Analysis for Human Genetic Disease [clinicaltrials:NCT00001898]Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma [clinicaltrials:NCT00002455]Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer [clinicaltrials:NCT00002460]High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma [clinicaltrials:NCT00002465]Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer [clinicaltrials:NCT00002498]High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer [clinicaltrials:NCT00002509]clinicaltrials:NCT00002528clinicaltrials:NCT00002529Tamoxifen in Treating Women With High-Risk Breast Cancer [clinicaltrials:NCT00002542]Mitoxantrone With or Without Docetaxel in Treating Women With Metastatic Breast Cancer [clinicaltrials:NCT00002544]Nutrition Intervention in Treating Women With Breast Cancer [clinicaltrials:NCT00002564]Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer [clinicaltrials:NCT00002579]Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer [clinicaltrials:NCT00002580]Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer [clinicaltrials:NCT00002581]Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer [clinicaltrials:NCT00002582]Pyrazoloacridine in Treating Women With Metastatic Breast Cancer [clinicaltrials:NCT00002585]Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer [clinicaltrials:NCT00002616]Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer [clinicaltrials:NCT00002627]Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast Cancer [clinicaltrials:NCT00002628]Tamoxifen for the Prevention of Breast Cancer in High-Risk Women [clinicaltrials:NCT00002644]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Breast Neoplasms [clinicaltrials_resource:fd46a662c92164802f60e654a768351f]
Bio2RDF identifier
fd46a662c92164802f60e654a768351f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:fd46a662c92164802f60e654a768351f
identifier
clinicaltrials_resource:fd46a662c92164802f60e654a768351f
title
Breast Neoplasms
@en
type
label
Breast Neoplasms [clinicaltrials_resource:fd46a662c92164802f60e654a768351f]
@en
Breast Neoplasms